Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis

QR Code

Beta-lactam antibiotics as reserve medications for the treatment of drug-resistant tuberculosis

The review article presents an analysis of literature data on the necessity to expand the range of medications possessing anti-tuberculosis activity for the treatment of the most severe forms of drug-resistant tuberculosis through the use of beta-lactam antibiotics in chemotherapy regimens. The mech...

Full description

Saved in:

Bibliographic Details
Main Authors:	G. N. Mozhokina, A. G. Samoilova, I. A. Vasilyeva
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2021-08-01
Series:	Антибиотики и Химиотерапия
Subjects:	drug-resistant tuberculosis beta lactams carbapenems anti-tuberculosis activity
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/823
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medication Errors Associated with Beta-Lactam Antibiotics: Analysis of Russian Spontaneous Reporting Database
by: A. V. Kuzmina, et al.
Published: (2020-05-01)

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics
by: S. V. Yakovlev, et al.
Published: (2020-05-01)

Dynamics of Acquires Resistance in the Main Gramnegative Pathogens of Surgical Infections to Beta-Lactams in 2004-2008
by: N. S. Bogomolova, et al.
Published: (2020-05-01)

Development of a UHPLC-UV/Vis Method for Simultaneously Determining Six Beta-Lactam Antibiotics in Plasma: A Tool for the Clinical Implementation of Therapeutic Monitoring of Beta-Lactams
by: Iria Varela-Rey, et al.
Published: (2025-06-01)

SNP Polymorphism in Genomes of CC320 Isolates of Streptococcus pneumoniae Resistant to Beta-Lactams
by: I. A. Tzvetkova, et al.
Published: (2020-05-01)

Neurotoxic Side Effects of Antimicrobial and Anti-Tuberculosis Drugs
by: G. N. Mozhokina, et al.
Published: (2020-08-01)

Rapid Analysis of the Sensitivity of Bacteria to Beta-Lactam Antibiotics by Using a Resonator with a Lateral Electric Field
by: O. I. Guliy, et al.
Published: (2020-05-01)

Cefepime/Sulbactam — A New Innovative Antibiotic for In-Hospital Treatment of Severe Infections and the Implementation of Carbapenem-Replacement Strategy to Contain Antibiotic Resistance
by: S. V. Yakovlev, et al.
Published: (2021-06-01)

Effect of reserved line’s anti-tuberculosis medicines to antiinflammatory cytokine production for patients with pulmonary tuberculosis
by: T. Ye. Kononova, et al.
Published: (2010-10-01)

Risk Factors and Characteristics of Adverse Reactions Associated with the Use of Beta-Lactam Antibiotics in Older Patients
by: E. A. Sokova, et al.
Published: (2021-10-01)

The Effectiveness of a Succinate-Containing Medication in Accompanying Therapy of Comorbid Tuberculosis in a Penitentiary Institution
by: V. M. Kolomiets, et al.
Published: (2020-12-01)

Unusual Co-existence of Drug-Susceptible Lung Tuberculosis and Drug-Resistant Pleural Tuberculosis: A Rare Case Presentation of Dual Infection
by: Herikurniawan Herikurniawan, et al.
Published: (2025-07-01)

Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis
by: N. Yu. Nikolenko, et al.
Published: (2021-07-01)

The eﬀectiveness of psychological support with the use of hepato-immunoprotectors as predictors in drug therapy of tuberculosis
by: V. M. Kolomiets, et al.
Published: (2021-08-01)

Detection and clinical analysis of drug-induced antibodies related to β-lactam antibiotics
by: ZHENG Yangyang, et al.
Published: (2025-07-01)

Puzzling Clinical Appearance of a Pancreatic Tuberculosis Case
by: Anak Agung Fendy Tri Wicaksana, et al.
Published: (2023-11-01)

Definition of drug resistance of Mycobacterium tuberculosis to antituberculosis drugs in patients with multidrugresistant tuberculosis and TB with extremely drug resistant depending on the case of the disease.
by: D. G. Kryzhanovsky, et al.
Published: (2014-11-01)

Effectiveness of β-lactam and Macrolide Antibiotic Combination in Patients with Community-Acquired Pneumonia: A Review
by: Nurul Hikmah, et al.
Published: (2025-06-01)

Viability of causative pathogen in patients with drug-sensitive and drug-resistant forms of respiratory tuberculosis
by: E. Yu. Zorkaltseva, et al.
Published: (2017-09-01)

Quantitative release assessment for beta-lactamase-producing Escherichia coli of dairy origin into vegetables
by: Kohei Makita, et al.
Published: (2024-09-01)

Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance when applied in paucibacillary clinical samples
by: Wenting Jin, et al.
Published: (2025-07-01)

Multi-drug-resistance in newly identified patients with tuberculosis in the Sakha Republic (Yakutia)
by: L. P. Yakovleva, et al.
Published: (2018-04-01)

Features of renal tuberculosis and other extrapulmonary tuberculosis localizations, depending on the presence or absence of the diagnosis confirmation in children
by: N. I. Porkulevich, et al.
Published: (2021-03-01)

Clinical manifestations and outcomes of tuberculosis in children in the Irkutsk region
by: S. G. Zvonkova, et al.
Published: (2016-04-01)

Medical care information support for patients with drug-resistant tuberculosis in the Kemerovo Region
by: S. V. Saranchina, et al.
Published: (2012-08-01)

Urogenital tuberculosis in children 0 - 14 years old in the structure of other localizations of tuberculosis
by: I. V. Drozdetskaya, et al.
Published: (2021-07-01)

EFFICIENCY OF INPATIENT TREATMENT OF TUBERCULOSIS PATIENTS WITH DRUG-RESISTANT TB
by: I. F. Kopylova, et al.
Published: (2013-02-01)

A case of shoulder tuberculosis: Diagnostic challenges and insights
by: Oukassem Siham, et al.
Published: (2025-09-01)

Cycloserine resistance among drug-resistant tuberculosis cases in Taiwan
by: Sheng-Han Wu, et al.
Published: (2025-07-01)

Resistance pattern and profile of patients with drug-resistant tuberculosis at a tertiary care center
by: Pratik Kumar, et al.
Published: (2025-07-01)

Tuberculosis cutánea (Escrofuloderma)
by: Martín Camilo Cárdenas Hernández, et al.
Published: (2002-02-01)

Social aspects multi-drug resistant tuberculosis
by: O. V. Filinyuk, et al.
Published: (2012-08-01)

In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic <i>E. coli</i>
by: Ali Atoom, et al.
Published: (2025-06-01)

Communicable Episode 20: Tuberculosis today
by: Kathryn Hostettler, et al.
Published: (2025-06-01)

Multiple Drug Resistance of Mycobacterium tuberculosis Isolated from New Cases of Respiratory Tract Tuberculosis
by: B. S. Kibrik, et al.
Published: (2020-05-01)

Toxicity of treatment regimens for drugresistant tuberculosis.
by: G. N. Mozhokina, et al.
Published: (2022-03-01)

Changes of Antimicrobial Resistance Causing Infections Following Transrectal Prostate Biopsy: Analysis of 10-Year Data
by: Da Eun Han, et al.
Published: (2021-12-01)

EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
by: I. A. Morozov, et al.
Published: (2016-11-01)

Nonfunctioning Kidney Due to Renal Tuberculosis: A Diagnostic Challenge
by: Madhuri Singh, et al.
Published: (2025-04-01)

COMPARATIVE STUDY OF M. TUBERCULOSIS GENOTYPES FROM BORDER DISTRICTS OF MONGOLIA AND BURYATIA
by: S. N. Zhdanova, et al.
Published: (2014-04-01)